Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy

E-ISSN： 1527-6473|21|8|1066-1075

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.8, 2015-08, pp. : 1066-1075

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Risk of End‐Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 1600-6135, Iss. 10, 2015-10 ,pp. : 2732-2738

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Risk of End‐Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2732-2738

John Wiley & Sons Inc

Access to resources Recommend Favorite

Boceprevir in liver transplant recipients

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 192-197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal transplant outcomes in primary FSGS compared with other recipients and risk factors for recurrence: A national review of the Irish Transplant Registry

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors and clinical outcomes of pediatric liver transplant recipients with post‐transplant lymphoproliferative disease in a multi‐ethnic Asian cohort

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite